Seres Therapeutics, Inc.
MCRB$72M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaCAMBRIDGE103 employees
Drugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Aug 5, 2026
7wMarket Overview
Stock performance and key metrics
MCRB News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
SER-109 | Phase 3 | Clostridium Difficile Infection | - | - |
Clostridium Difficile Infection
1 drug in this indication
Clostridium Difficile
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply